The value of Institute of Human Virology meeting abstracts and beyond by Jeang, Kuan-Teh
BioMed  Central
Page 1 of 2
(page number not for citation purposes)
Retrovirology
Open Access Editorial
The value of Institute of Human Virology meeting abstracts and 
beyond
Kuan-Teh Jeang*
Address: The National Institutes of Health, Bethesda, Maryland, USA
Email: Kuan-Teh Jeang* - kj7e@nih.gov
* Corresponding author    
Abstract
This month Retrovirology publishes the meeting abstracts from the 10th annual Institute of Human
Virology conference held August 29th to September 2nd, 2005 in Baltimore, Maryland, USA. In this
editorial, the rationale for publishing meeting abstracts is discussed.
To celebrate the 10th annual meeting of the Institute of
Human Virology (IHV), Retrovirology  publishes this
month a supplement [1] which includes 315 abstracts of
presentations that took place August 29th to September
2nd, 2005 in Baltimore, Maryland, USA. This compilation
of meeting abstracts, as with all other items published in
Retrovirology, will be listed in PubMed, indexed in
MedLine, and permanently archived in PubMed Central.
The IHV abstracts will be available for all to read in an
unrestricted "Open Access" manner. This latter privilege is
important because fully two-thirds of the users of free and
open data bases such as PubMed are in fact not academics.
The users may be patients, students, teachers, or health-
care professionals; and they would be barred from infor-
mation-access by a fee-based format.
Is there value to publishing Meeting Abstracts? On several
levels, the answer appears to be "yes". While the IHV
abstracts are the first of its kind for Retrovirology, our expe-
rience with publishing meeting reports [2-5] tells of
strong readership interest. Our statistics show that the
published 2004 Cold Spring Harbor Retrovirus Meeting
Report [2], a meeting attended by ~500 conferees, has
been read in Retrovirology  3668 times over the past 14
months. A separate report of the 2005 Twelfth West Coast
Retrovirus meeting [5], attended by ~125 scientists, was
accessed 610 times in the first ten days after its publica-
tion. Independently, Scherer et al. [6] found in a study of
2,391 meeting abstracts that 51% of the abstracts later
appeared as full articles in journals. In another survey,
84% of journals were found to permit the citation of
meeting abstracts in bibliographies [7]. Because on aver-
age an entire year lags between the time that a paper/
poster is presented at a meeting and its eventual publica-
tion in a journal, publishing meeting abstracts arguably
serves to narrow a knowledge gap between those who
attended a meeting and those who did not [7]. Moreover,
extant data support that the "open access" approach to
publishing scientific information promotes a higher rate
of citation to the published work [8]. Thus, it stands to
reason that there is value for both authors and readers of
Retrovirology meeting abstracts.
Let me close this writing by telling you a personal anec-
dote which illustrated for me why archiving of meeting
abstracts is important. In the early 1980's, I was a graduate
student working in one of three laboratories worldwide
which were competing on the cloning and the characteri-
zation of the cytomegalovirus (CMV) immediate-early
(IE) promoter. This is the same CMV promoter that is res-
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ident in the many mammalian expression vectors which
most of you purchase commercially. My memory tells me
(although my memory has faded with age) that between
1981 to 1984, I made several presentations on CMV pro-
moter research at the then annual Herpesvirus meeting
held at Cold Spring Harbor. Later, in 1990, a patent for
the use of the CMV IE promoter was filed by a competi-
tor's group. Many years passed, until approximately five
years ago when I unexpectedly received a telephone call
from a patent attorney at a high-priced law firm in New
York City. The attorney represented a biotech firm which
was keen on contesting the issued CMV IE patent. The
attorney wanted to know "What did I say publicly about
my CMV IE promoter research at meetings?" "And when
did I say them?". I recall at that moment when confronted
to recall accurately minute historical details critical to a
legal contest, I wished fervently for the existence of an
open access, easily searchable, repository of meeting
abstracts.
Retrovirology is committed to the goal of free public access
to permanently archived digitally formatted scientific
information. Meeting abstracts published in Retrovirology
are initially viewable online in our journal, and are then
permanently deposited into the PubMed Central archive.
Retrovirology is currently accessed ~1,000 times daily. If
you are a meeting organizer interested in the rapid and
broad dissemination (with permanent archiving) of the
presentations from your conference, it may be worth your
while to consider publishing your meeting in Retrovirol-
ogy.
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